| Aspira Pathlab & Diagnostics Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 540788 |
NSE Symbol : - |
P/E(TTM) : 20.45 |
|
ISIN Demat : INE500C01017 |
Div & Yield% : 0.00 |
EPS(TTM) : 3.31 |
|
Book Value(₹) : 14.01 |
Market Cap(₹Cr) : 69.66 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 8.09 | 5.25 | 5.78 | 5.41 | 6.18 | 4.64 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 8.09 | 5.25 | 5.78 | 5.41 | 6.18 | 4.64 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.14 | 0.11 | 0.13 | 0.09 | 0.08 | 0.09 |
| Total Income | 8.23 | 5.36 | 5.91 | 5.50 | 6.25 | 4.73 |
| Total Expenditure | 5.90 | 4.43 | 4.72 | 4.64 | 4.82 | 4.29 |
| PBIDT | 2.33 | 0.93 | 1.18 | 0.86 | 1.43 | 0.44 |
| Interest | 0.10 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 |
| PBDT | 2.23 | 0.83 | 1.09 | 0.76 | 1.35 | 0.36 |
| Depreciation | 0.40 | 0.37 | 0.37 | 0.39 | 0.36 | 0.38 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 1.84 | 0.47 | 0.72 | 0.38 | 0.99 | -0.02 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.84 | 0.47 | 0.72 | 0.38 | 0.99 | -0.02 |
| EPS (Unit Curr.) | 1.78 | 0.46 | 0.70 | 0.37 | 0.96 | -0.02 |
| EPS (Adj) (Unit Curr.) | 1.78 | 0.46 | 0.70 | 0.37 | 0.96 | -0.02 |
| Calculated EPS (Unit Curr.) | 1.78 | 0.46 | 0.70 | 0.37 | 0.96 | -0.02 |
| Calculated EPS (Adj) (Unit Curr.) | 1.78 | 0.46 | 0.70 | 0.37 | 0.96 | -0.02 |
| Calculated EPS (Ann.) (Unit Curr.) | 7.13 | 1.82 | 2.81 | 1.46 | 3.85 | -0.06 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 7.13 | 1.82 | 2.81 | 1.46 | 3.85 | -0.06 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.29 | 10.29 | 10.29 | 10.29 | 10.29 | 10.29 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 28.80 | 17.71 | 20.42 | 15.90 | 23.14 | 9.48 |
| PBDTM(%) | 27.56 | 15.81 | 18.86 | 14.05 | 21.84 | 7.76 |
| PATM(%) | 22.74 | 8.95 | 12.46 | 7.02 | 16.02 | -0.43 |